Natixis Advisors LLC Has $17.12 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Natixis Advisors LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 29.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 209,175 shares of the company’s stock after acquiring an additional 48,009 shares during the quarter. Natixis Advisors LLC’s holdings in HealthEquity were worth $17,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the business. International Assets Investment Management LLC bought a new stake in shares of HealthEquity during the second quarter valued at approximately $35,000. Paladin Wealth LLC bought a new stake in shares of HealthEquity during the third quarter valued at approximately $39,000. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the second quarter valued at approximately $73,000. Finally, 1620 Investment Advisors Inc. bought a new stake in shares of HealthEquity during the third quarter valued at approximately $112,000. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on HQY. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. The Goldman Sachs Group initiated coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Finally, BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $107.23.

Insiders Place Their Bets

In other news, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 20.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock worth $884,517 in the last ninety days. 2.20% of the stock is currently owned by insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $102.67 on Wednesday. The firm has a market capitalization of $8.97 billion, a P/E ratio of 85.56, a P/E/G ratio of 1.55 and a beta of 0.52. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock’s 50-day simple moving average is $86.10 and its two-hundred day simple moving average is $81.42. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $103.12.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The business had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. As a group, equities analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.